Intraperitoneal infusion of ex vivo-cultured allogeneic NK cells in recurrent ovarian carcinoma patients (a phase I study)

INTRODUCTION: Recurrent ovarian carcinoma has dismal prognosis, but control of disease and prolonged survival are possible in some patients. The estimated 5-year survival is 46% for all stages of ovarian cancer, and only 28% for metastasized disease. Notably, the majority of women with ovarian cance...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Hoogstad-van Evert, Janneke, Bekkers, Ruud, Ottevanger, Nelleke, Schaap, Nicolaas, Hobo, Willemijn, Jansen, Joop H., Massuger, Leon, Dolstra, Harry
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6380776/
https://ncbi.nlm.nih.gov/pubmed/30702598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000014290
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak